October 18, 2007 - Abbott announced that trial results for ABSORB, the world’s first clinical trial evaluating the safety and performance of a fully bioabsorbable drug eluting stent platform for the treatment of coronary artery disease, are positive.
October 18, 2007 - Possis Medical Inc. featured the newest and the most important advancements in its "Complete Solution for Thrombus" at TCT 2007, including the AngioJet Ultra Thrombectomy System, AngioJet Spiroflex and Spiroflex VG catheters and its Fetch Aspiration Catheter.
October 18, 2007 - Vascular Solution Inc. spotlights its Guardian hemostasis valve and Gopher Support Catheter at TCT ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
October 18, 2007 - Boston Scientific Corp. today announced it will restructure or sell several business units to reduce operating expenses by 13 percent in 2008 in a move designed to enhance short- and long-term shareholder value.
October 18, 2007 - This year at TCT ProSolv CardioVascular, a FUJIFILM company and leading provider of enterprise-level ...
During the last several decades, the prevalence of Methicillin-Resistant Staphylococus Aureus (MRSA) and other ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
October 18, 2007 - Guerbet will feature at TCT 2007 its x-ray contrast agent, Oxilan (ioxilan) injection, a contrast ...
October 18, 2007 – XTENT Inc. announced that two-year data from the CUSTOM I trial and 1-year data from the CUSTOM II ...
October 18, 2007 - Combining all of the features of the ACIST CMS and Voyager systems onto one platform, the ACIST CVi ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
October 18, 2007 - Toshiba America Medical Systems Inc. is showcasing its suite of workflow and storage enhancements for ...
October 18, 2007 - At TCT 2007, Philips Medical Systems is presenting two live interventional cases with the University ...
October 17, 2007 — Patients with heart disease who undergo coronary angioplasty have an equivalent risk of death and heart attack as patients who undergo coronary bypass surgery, according to Stanford University School of Medicine researchers.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Agfa HealthCare’s DX-S reportedly fills the gap in the current range of Digital Radiography Solutions by providing a ...
The FDA gave ZOLL Medical Corp., a manufacturer of resuscitation devices and related software solutions, clearance to market and sell the ZOLL AED Pro with See-Thru CPR technology, which is designed to help minimize interruptions in CPR. ZOLL aims to comply with a key recommendation of the American Heart Association’s Guidelines for Advanced Cardiac Life Support.
October 17, 2007 - Positron Corp. introduced its new dedicated-Cardiac PET system, Attrius, at the annual meeting of the ...
October 17, 2007
